Treatment of melanoma with alpha thymosin peptides in...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61K 31/4164 (2006.01) A61K 31/44 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)

Patent

CA 2708229

Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administer-ing a melanoma-treating combination to a human melanoma patient during a treatment regimen, the combination including an alpha thymosin peptide and a kinase inhibitor.

Selon la présente invention, un mélanome, ou une métastase produite par celui-ci, est traité chez un patient humain par une polythérapie. Celle-ci consiste à administrer à un patient humain souffrant d'un mélanome une combinaison anti-mélanomique selon un schéma thérapeutique, la combinaison incluant un peptide d'alpha thymosine et un inhibiteur de kinase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of melanoma with alpha thymosin peptides in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of melanoma with alpha thymosin peptides in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of melanoma with alpha thymosin peptides in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1668946

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.